← Open Payments lookup

USMAN TOHID: Open Payments

NPI 1508292483 · FLORENCE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,141 in 45 payments from 10 companies in 2025. Trend: 2023 $1,700 · 2024 $1,568 · 2025 $1,141

Food & beverage: $1,141
CompanyPaymentsAmount
ABBVIE INC.11$226
Janssen Pharmaceuticals, Inc3$195
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$189
E.R. Squibb & Sons, L.L.C.6$184
Alkermes, Inc.10$182
Otsuka America Pharmaceutical, Inc.3$60
Neurocrine BioSciences, Inc.2$41
Teva Pharmaceuticals USA, Inc.2$31
Lundbeck LLC1$19
Axsome Therapeutics, Inc.1$14

Products named: VRAYLAR, INVEGA SUSTENNA, CAPLYTA, COBENFY, ARISTADA, REXULTI, INGREZZA, ABILIFY ASIMTUFII.

Industry payments across SC — which companies pay providers there.